GI Side Effects In Depth

If you’ve been on a GLP-1 medication for more than a few days, you probably know that nausea gets most of the attention. And we’ve got a whole page on managing that. But your GI tract is a long system, and GLP-1 medications affect all of it — not just your stomach. Diarrhea, constipation, bloating, acid reflux, and abdominal pain are all part of the picture, and they each have their own patterns, timelines, and management strategies.

This page covers the GI side effects that aren’t nausea — what causes them, how long they typically last, and what people actually do about them. Some of this you may be dealing with right now. Some of it you may never experience. Either way, knowing what’s happening and why takes a lot of the anxiety out of it.


Diarrhea

Diarrhea is the second most commonly reported GI side effect after nausea. In clinical trials, about 30% of people on semaglutide (Wegovy) experienced it at some point, compared to 16% on placebo. For tirzepatide (Mounjaro/Zepbound), rates were a bit lower — roughly 19-23% depending on the dose.[1][2]

Those numbers sound high, but here’s the reassuring part: diarrhea episodes on GLP-1 medications are typically short. The median episode lasted just 3 days in clinical trials — making it the shortest-lasting common GI side effect.[1] Most episodes come and go, especially around dose increases.

Why It Happens

A few things are going on at once. GLP-1 medications change how quickly food and fluids move through your intestines. While the stomach slows down, the lower part of your digestive tract can respond differently — and for some people, that means things move through the colon faster or with more fluid than usual.

There’s also a bile acid connection. GLP-1 medications affect your gallbladder and the timing of bile release. When excess bile acids reach the colon, they act as a natural laxative — drawing water into the bowel and speeding things up.[3]

And there’s a simpler factor: dietary changes. When you start eating less, eating differently, or suddenly cutting back on fats, your gut needs time to adjust. That adjustment can show up as loose stools for a while.

What Helps

Stay hydrated — diarrhea means fluid loss, and GLP-1s can suppress thirst. Drink water throughout the day.[4]

Keep it bland — bananas, rice, toast, plain chicken. Avoid greasy, spicy, or high-fiber foods until things calm down.

Watch artificial sweeteners — sorbitol and xylitol (sugar-free gum, protein bars, diet drinks) have a laxative effect on their own.

Don't preemptively medicate — some people alternate diarrhea and constipation. Treat what's happening now, not what might happen.[5]

Pro Tip:

If you’re getting diarrhea mainly in the first day or two after your injection and it settles by mid-week, that pattern suggests your body is reacting to the peak drug levels. Mention this to your provider — the timing tells them useful information about how you’re responding.


Constipation

This one surprises a lot of people. How can a medication cause both diarrhea and constipation? Different mechanisms — and sometimes, they even alternate in the same person.

About 24% of people on semaglutide experienced constipation in clinical trials, compared to 11% on placebo. Tirzepatide rates were lower — roughly 7-17% depending on the dose and trial.[1][2]

But here’s what makes constipation different from the other GI side effects: it lasts longer. While nausea episodes averaged 8 days and diarrhea averaged 3 days, constipation had a median duration of 47 days.[1] It also doesn’t follow the same “peaks during dose escalation then fades” pattern — it tends to plateau early and persist.

Why It Happens

Two things are working together. First, GLP-1 medications slow down your entire digestive tract — not just your stomach. When food moves through the colon more slowly, more water gets absorbed out of it, leading to harder, drier stools. A 2025 study using wireless motility capsules found that 44% of GLP-1 patients had delayed whole-gut transit time.[6]

Second — and this is the one people don’t think about — you’re eating less. Less food means less bulk moving through your system. And if you’re eating less fiber (because you’re eating less of everything), that compounds the problem.

What Helps

Hydration first — fiber without adequate fluid makes things worse. Target ~73 oz/day (women), ~100 oz/day (men).[7]

Get fiber up — gradually — aim for 25–34g daily, increase ~5g/week. Psyllium husk is well-supported.[7]

Move your body — even a 10–15 min walk after meals stimulates intestinal contractions. 150 min/week of moderate activity helps.

If lifestyle isn't enough — polyethylene glycol (MiraLAX) is the first-line option. Draws water into the colon to soften stool.[7]

From Brandon's Experience:

Constipation was the sneaky one for me. I was so focused on nausea (which came and went) that I didn’t notice the constipation creeping in until it had been going on for a while. Once I realized I was eating about half the fiber I used to — because I was eating half the food I used to — it made sense. Psyllium husk in my morning water became a non-negotiable. Boring? Yes. Effective? Absolutely.


Bloating, Gas, and the Sulfur Burps

If you’ve been on GLP-1 Reddit or Facebook groups for more than ten minutes, you’ve probably seen someone mention the sulfur burps. They’re real, they’re unpleasant, and they’re more common than the clinical trial numbers suggest — because trial reporting tends to categorize them under broader terms like “eructation” (medical term for belching) or “abdominal distension” (bloating).

In clinical trials, abdominal distension was reported by about 7% of semaglutide patients, belching by about 6%, and flatulence was also listed as a common side effect.[8] The real-world numbers are likely higher — these aren’t the kind of symptoms most people bring up in a clinical visit.

Why It Happens

When food sits in your stomach and intestines longer (which is exactly what GLP-1 medications do), bacteria in your gut have more time to ferment it. That fermentation produces gas — hydrogen, methane, and yes, sulfur compounds that can come up as those distinctive sulfur burps.

Bloating often comes from the same basic problem: a slower-moving digestive system means food and gas have fewer places to go. Your stomach is fuller for longer, your intestines are moving at a slower pace, and the result is that full, pressured, distended feeling.

Dietary changes can make it worse. If you’ve started eating more fiber (good for constipation), adding it too quickly can make gas and bloating worse before it gets better.

What Helps

Smaller meals — less food in a slow-moving system means less bloating at any given time.

Chew slowly — eating fast means swallowing more air, which directly contributes to belching and bloating.

Cut carbonated drinks — you're adding gas to a system already struggling to move it through.

Ease into fiber — beans, broccoli, cauliflower, and onions are gas-producing. Introduce gradually.

Walk after meals — 10–15 minutes stimulates motility and moves gas through.

Simethicone (Gas-X) — breaks up gas bubbles, available OTC, well-tolerated for acute relief.

The good news: bloating and gas tend to resolve within 2-6 weeks as your body adapts. The sulfur burps in particular are usually most intense early on and during dose increases.


Acid Reflux and Heartburn

This one doesn’t get talked about as much as the others, but it’s more common than most people realize. Both semaglutide and tirzepatide list GERD (gastroesophageal reflux disease) and dyspepsia (an umbrella term for upper stomach discomfort) at 5% or higher in their prescribing information.[8][9]

A large 2025 study comparing over 24,000 GLP-1 users to nearly 90,000 patients on a different diabetes medication found that GLP-1 users had a 27% higher risk of developing GERD — a real but relatively modest increase (about 0.7 extra cases per 100 patients). More notably, the risk of GERD complications was 55% higher.[10]

Why It Happens

The mechanism is straightforward: your stomach is emptying more slowly, so it’s fuller for longer. A full stomach puts more pressure on the valve between your stomach and esophagus (called the lower esophageal sphincter). When that valve faces sustained pressure, stomach acid is more likely to push upward — and that’s reflux.

If you already have a tendency toward reflux or a hiatal hernia, GLP-1 medications can make it worse. The good news: since excess weight is itself a major driver of GERD, the weight loss from GLP-1 therapy tends to improve reflux over time. So some people experience a paradox — more reflux early on that gradually gets better as they lose weight.

What Helps

Smaller meals — less food in the stomach means less upward pressure on the esophageal valve.

Don't eat close to bedtime — at least 2–3 hours between last meal and lying down. Even more important on a GLP-1.

Elevate the head of your bed — even 4–6 inches makes a meaningful difference for nighttime reflux.

Avoid common triggers — fatty foods, spicy foods, caffeine, alcohol, and carbonated beverages.

OTC acid reducers — antacids, H2 blockers, or PPIs. Need for these typically decreases over time as the body adjusts.[4]

Talk to Your Provider:

If you had GERD or acid reflux before starting a GLP-1, let your provider know. They may want to monitor you more closely, adjust your reflux treatment, or factor it into your dose escalation strategy. And if you develop new reflux symptoms that are severe, persistent, or worsening — especially difficulty swallowing or chest pain — that warrants a conversation.


Abdominal Pain

General abdominal pain or discomfort was reported by about 20% of people on semaglutide in clinical trials.[1] It’s a broad symptom — it can come from any of the specific issues we’ve covered above (bloating, constipation, reflux, gas). Most of the time, it’s a consequence of the same underlying mechanism: food moving more slowly through a digestive system that’s still adjusting.

From my experience, the abdominal discomfort most people describe isn’t sharp or severe — it’s more of a dull fullness, like you ate a big meal when you didn’t. It tends to come and go, worsens after eating too much or too fast, and improves as the body adjusts to the medication.

The management strategies are the same ones that run through this entire page: smaller meals, slower eating, good hydration, gentle movement after eating, and patience as your body adapts.

When to pay attention: Abdominal pain that’s sudden, severe, doesn’t go away, or is localized to a specific area (especially the upper right side, which could suggest gallbladder issues, or the upper middle/left side radiating to the back, which could suggest pancreatic inflammation) is different from the general discomfort most people experience. That kind of pain warrants a call to your provider. See our When to Contact Your Doctor page for the full list of warning signs.


The Gastroparesis Question

If you’ve been reading about GLP-1 medications online, you’ve probably seen the word “gastroparesis” — and it’s probably scared you. There are over 1,800 active lawsuits related to GLP-1 medications and gastroparesis. Headlines about “stomach paralysis” get a lot of clicks. The reality is more nuanced, and understanding it can save you a lot of unnecessary anxiety.

What Gastroparesis Actually Is

Gastroparesis — literally “stomach paralysis” — is a chronic condition where the muscles of the stomach don’t contract properly. It’s most often caused by nerve damage from diabetes, post-surgical complications, or unknown causes. Food sits in the stomach for abnormally long periods, leading to severe nausea, vomiting (sometimes of food eaten hours or even a full day earlier), and significant malnutrition.

The Important Distinction

Here’s what the headlines usually miss: delayed gastric emptying is how GLP-1 medications work. Slowing down your stomach isn’t a malfunction — it’s the intended pharmacologic effect. It’s part of what makes you feel full longer, eat less, and lose weight. Every single person on a GLP-1 medication has some degree of delayed gastric emptying. That’s the point.

True gastroparesis is different. It’s a disease of the stomach muscles themselves — not a temporary medication effect. And the clinical data consistently shows that the stomach-slowing effect of GLP-1 medications naturally diminishes over time. Researchers have documented this process — called tachyphylaxis — happening within hours to days of continuous GLP-1 exposure.[11] Your nervous system adapts. The stomach gets used to the signal and starts moving more normally again.

That’s the opposite of what happens with true gastroparesis, where things tend to stay the same or get worse.

How Rare Is the Real Thing?

From the FDA’s adverse event database (2007-2023), there were about 995 reports of delayed gastric emptying across all GLP-1 medications.[12] But that database doesn’t distinguish between the expected drug effect and actual pathology — so many of those reports likely describe the normal pharmacologic response. The clinical literature describes true gastroparesis from GLP-1 medications as “unusual.”

In the rare cases where it does occur, the pattern is important: in documented case reports, symptoms resolved completely after stopping the medication.[13] That’s the hallmark of a drug effect, not permanent nerve or muscle damage.

Important:

None of this means “tough it out if your stomach is miserable.” If GI symptoms are severe, worsening over time, or not improving despite dose adjustments, talk to your provider. The distinction between a rough adjustment period and something more concerning is exactly the kind of call your medical team is there to help you make.

When to Be Concerned

Most GI discomfort on GLP-1 medications is the normal adjustment your body goes through. But certain patterns should prompt a conversation with your provider:

Severe, persistent vomiting

Doesn't improve after the first few weeks. Especially vomiting food eaten many hours ago — a classic gastroparesis sign.

Complete inability to eat or keep food down

Not just reduced appetite (that's expected) — genuinely unable to eat.

Symptoms getting worse, not better

Or symptoms that don't improve at all when you pause or reduce the dose.

Dehydration or unexpected weight loss

Significant unintended weight loss beyond what you and your provider expect.


The Pattern That Runs Through All of This

If you’ve read this far, you’ve probably noticed some themes. Every GI side effect on this page shares the same root cause: GLP-1 medications slow down your digestive system, and your body needs time to adjust. And the management strategies overlap heavily — smaller meals, slower eating, staying hydrated, gentle movement, and patience.

A few things worth keeping in mind as you navigate all of this:

The timeline is different for each symptom

Diarrhea: a few days. Bloating/gas: 2–6 weeks. Nausea: peaks at maintenance dose, then fades. Constipation is the outlier — it can hang around longer and may need active management.

Dose escalation is the biggest trigger

Most GI side effects flare during dose increases and settle once your body adjusts. A bump in symptoms after an increase usually calms down within a week or two.

Hydration is the universal answer

Helps constipation, protects during diarrhea, supports digestion, and is extra important because GLP-1s can suppress your thirst signal. Drink more water than you think you need.

You don't need to push through misery

93–96% stay on treatment in trials.[14] But talk to your provider about extending escalation, stepping back a dose, or trying different strategies. There's real flexibility, and using it isn't failure.


Sources:

  1. Wharton, S. et al. “Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity.” Diabetes, Obesity and Metabolism, 2022.
  2. Jastreboff, A. M. et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine, 2022.
  3. Ghusn, W. et al. “Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide-1 Receptor Agonists.” Clinical and Translational Gastroenterology, 2025.
  4. “Ten Top Tips for the Management of GLP-1 Receptor Agonists in Adults within Primary Care.” Obesity Facts, 2025.
  5. Trujillo, J. M. et al. “GLP-1 Receptor Agonists: An Updated Review of Head-to-Head Clinical Studies.” PMC, 2023.
  6. “Impact of GLP-1 Receptor Agonists on Whole-Gut Gastrointestinal Motility Using Wireless Motility Capsule.” PMC, 2025.
  7. “Nutritional Priorities to Support GLP-1 Receptor Agonist Therapy for Obesity.” Joint Advisory from ACLM, ASN, OMA, and The Obesity Society. PMC, 2025.
  8. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2025.
  9. U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. 2025.
  10. “GLP-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes.” Annals of Internal Medicine, 2025.
  11. Nauck, M. A. et al. “Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans.” Diabetes, 2011.
  12. “Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists: A FAERS-Based Study.” Diagnostics, 2024.
  13. “Tendency of Semaglutide to Induce Gastroparesis: A Case Report.” PMC, 2024.
  14. Rubino, D. M. et al. “Gastrointestinal tolerability and weight reduction associated with tirzepatide — SURMOUNT-1 to -4 trials.” Diabetes, Obesity and Metabolism, 2025.

Want to Start Tracking Your Progress?

Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.

View Templates